(888) 552-6760 SCHEDULE AN APPOINTMENT

Adam Rock,

Medical Oncologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Education
Medical school:
Board Certification
  • 2019-present, California Medical License, California State Medical Board
Degrees
  • 2016, Doctor of Medicine, Chicago Medical School, Rosalind Franklin University, North Chicago, Illinois

  • 2012, Master of Science, Rosalind Franklin University, North Chicago, Illinois

  • 2011, Bachelor of Science, Michigan State University, East Lansing, Michigan

Fellowship
  • 2022, Hematology/Oncology, Harbor UCLA Medical Center, Los Angeles, California
Residency
  • 2019, Internal Medicine, University of Illinois at Chicago, Chicago, Illinois
Professional Experience
  • 2022 - present, Director, Medical Oncology In-patient Consult Services
  • 2022-present, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, California
     
Academic Appointments
  • Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
About Me

Medical oncologist Adam Rock, M.D., grew up in a family of health care providers, a background that allowed him to see firsthand how meaningful and rewarding the relationship between provider and patient can be. Personal family encounters with cancer continue to provide meaning and motivation to his work, as he enjoys the opportunity to work at the intersection of leading-edge research and meaningful human interaction.

Joining City of Hope in 2022 after serving as a fellow there, Dr. Rock considers it the ideal setting to provide high-quality care and collaborate with regional and international experts in a range of fields. During his time as a resident at the University of Illinois at Chicago, he was recognized with the American Society of Hematology's Abstract Achievement Award, and he went on to serve as chief fellow in Oncology/Hematology at Harbor-UCLA Medical Center. As a physician-scientist, he has played a role in leading 10 previous and ongoing clinical trials as of 2019.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.